Tributary Capital Management LLC Acquires 1,634 Shares of Balchem Co. (NASDAQ:BCPC)

Tributary Capital Management LLC boosted its holdings in Balchem Co. (NASDAQ:BCPC) by 1.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 136,255 shares of the basic materials company’s stock after purchasing an additional 1,634 shares during the quarter. Balchem makes up approximately 1.7% of Tributary Capital Management LLC’s holdings, making the stock its 22nd biggest position. Tributary Capital Management LLC owned 0.42% of Balchem worth $22,209,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. FMR LLC boosted its position in shares of Balchem by 944.3% during the third quarter. FMR LLC now owns 497,495 shares of the basic materials company’s stock worth $87,559,000 after acquiring an additional 449,854 shares during the last quarter. Victory Capital Management Inc. increased its holdings in Balchem by 129.7% in the 3rd quarter. Victory Capital Management Inc. now owns 98,853 shares of the basic materials company’s stock valued at $17,398,000 after acquiring an additional 55,822 shares during the last quarter. Barclays PLC increased its holdings in Balchem by 405.8% in the 3rd quarter. Barclays PLC now owns 60,777 shares of the basic materials company’s stock valued at $10,695,000 after acquiring an additional 48,762 shares during the last quarter. Congress Asset Management Co. increased its holdings in Balchem by 12.4% in the 3rd quarter. Congress Asset Management Co. now owns 301,440 shares of the basic materials company’s stock valued at $53,053,000 after acquiring an additional 33,373 shares during the last quarter. Finally, Geode Capital Management LLC increased its holdings in Balchem by 3.1% in the 3rd quarter. Geode Capital Management LLC now owns 928,904 shares of the basic materials company’s stock valued at $163,514,000 after acquiring an additional 27,979 shares during the last quarter. 87.91% of the stock is owned by hedge funds and other institutional investors.

Balchem Stock Performance

Shares of NASDAQ:BCPC opened at $160.23 on Friday. Balchem Co. has a 52 week low of $137.69 and a 52 week high of $186.03. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21. The firm has a fifty day simple moving average of $168.92 and a two-hundred day simple moving average of $170.82. The stock has a market capitalization of $5.21 billion, a P/E ratio of 43.07, a PEG ratio of 4.36 and a beta of 0.69.

Balchem Increases Dividend

The company also recently declared an annual dividend, which was paid on Friday, January 17th. Investors of record on Thursday, December 26th were paid a dividend of $0.87 per share. The ex-dividend date was Thursday, December 26th. This is a boost from Balchem’s previous annual dividend of $0.79. This represents a dividend yield of 0.4%. Balchem’s payout ratio is currently 23.39%.

Analysts Set New Price Targets

BCPC has been the subject of a number of recent research reports. StockNews.com raised shares of Balchem from a “hold” rating to a “buy” rating in a research note on Monday, October 28th. HC Wainwright lifted their price objective on shares of Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Monday, November 4th.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.